Skip to main content


Health

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.
463 of 1450




Newsletter Sign Up

Daily Readings

Reading 1, Isaiah 49:1-6
Coasts and islands, listen to me, pay attention, distant ... Read More

Psalm, Psalms 71:1-2, 3-4, 5-6, 15, 17
In you, Yahweh, I take refuge, I shall never be put to shame. ... Read More

Gospel, John 13:21-33, 36-38
Having said this, Jesus was deeply disturbed and declared, 'In ... Read More

Saint of the Day

April 15 Saint of the Day

St. Paternus
April 15: St. Paternus.The first 5th century saint. He followed his ... Read More